Use of antibiotics in an Italian children's hospital, 1993-1995; clinical and economic considerations

International Journal of Antimicrobial Agents

Volumn 14, Issue 1, 2000, Pages 33-37

  Bassetti, Matteo ^a   Collidà, Andrea ^a   Rossi, Rossella ^b   Cruciani, Mario ^a   Di Biagio, Antonio ^a   Bassetti, Dante ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Antimicrobial agents; Cost; Pediatric hospital; Use

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN; GENTAMICIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BUDGET; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HOSPITAL ADMISSION; HUMAN; ITALY; PEDIATRICS; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; DRUG UTILIZATION; HOSPITALIZATION; HOSPITALS, PEDIATRIC; HUMANS;

EID: 0034050251     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00137-5     Document Type: Article

References (18)

1. Drummond M.F., Stoddard G.L., Torrance G.W. Methods for the Economic Evaluation of Health Care Programmes. 1987;Oxford Medical, Oxford.
2. Taylor D. Prescribing in Europe - forces for change. Br. Med. J. 304:1992;239-242.
3. Coleman R.W., Rodondi L.C., Kaubisch S., Granzella N.B., O'Hanley P.D. Cost-effectiveness of prospective and continous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am. J. Med. 90:1991;439-444.
4. Bassetti D., Capri S. Criteri di scelta degli antibiotici iniettabili in ospedale: aspetti clinici ed economici. Antibioticoterapia per la pratica. 2:1993;29-50.
5. Liss R.H., Batehelor F.R. Economic evaluation of antibiotic use and resistance. A perspective: report of task force 6. Rev. Infect. Dis. 9(Suppl 3):1987;S297-311.
6. Janknegt R., Wijnands W.J.A., Caprasse M., Brandeburg W., Schuitenmaker M.G., Stoibberinh E. Antimicrobial drug use in hospital in the Netherlands, Germany and Belgium. Eur. J. Clin. Microbiol. Infect. Dis. 12:1993;832-838.
7. Fletcher C.V. et al. Patterns of antibiotic use and expenditures: seven years at university hospital. Pharmacotherapy. 10:1990;199-204.
8. Guay D.R.P. Newer antibiotics in the managed care settings. Drug Benefit Trend. 7(7):1993;39-46.
9. Bassetti D., Fioredda F., Lorusso C. et al. Analisi del consumo di antibiotici e relativa spesa in un ospedale pediatrico (Istiuto G.Gaslini) nell'anno 1993: studio preliminare. Farmaci. 19(6):1997;167-174.
10. WHO. Anatomical Therapeutic Chemical (ATC) Classifification Index including Defined Daily Doses (DDDs) WHO Collaborating Centre for Drug Statistics.
11. Clark K.W., Gray D. The defined daily dose as a tool in pharmacoeconomics. Advantages and limitations. Pharmacoeconomics. 7(4):1995;280-283.
12. de Lalla F. Antimicrobial agents rational and monitoring in an Italian hospital. J. Chemother. 8(5):1996;342-350.
13. Halls G.A. The management of infections and antibiotic therapy: a European survey. JAC. 31:1993;985-1000.
14. Martini N., Scroccaro G., Sala M.L., Olivencia P. Antiinfectives consumption in a group of hospital in three Mediterranean countries. Mueller N.F., Hekster Y.A. Progress in Clinical Pharmacy. 1990;220-221 European Society of Clinical Pharmacy, Noordwijk, The Netherlands.
15. Manno G., Mantero E., Ugolotti E. et al. Antimicrobial susceptibility of Staphylococcus epidermidis strains in a pediatric hospital: a review from 1992 to 1997. Proceedings of the 38th ICAAC, San Diego, CA, September. 1998;. Abs. K-67.
16. Davey P.G., South R., Malek M. Impact of glycopeptide therapy after hospital discharge on inpatient costs: a comparison of teicoplanin and vancomycin. J. Antimicrob. Chemother. 37:1996;623-633.
17. Schaad U.B. Use of quinolones in pediatrics. Eur. J. Clin. Infect. Dis. 10:1991;355-360.
18. Cooke J. Cost issue in sequential therapy. J. Infect. 37(Suppl 1):1998;45-50.